SB
BIO icon

Suntrust Banks’s Bio-Rad Laboratories Class A BIO Stock Holding History

Suntrust Banks’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$3.47M Buy
10,439
+83
+0.8% +$27.1K 0.02% 431
2019
Q2 		$3.24M Sell
10,356
-27
-0.3% -$8.09K 0.02% 455
2019
Q1 		$3.17M Buy
10,383
+2,849
+38% +$769K 0.02% 437
2018
Q4 		$1.75M Sell
7,534
-348
-4% -$93.4K 0.01% 558
2018
Q3 		$2.47M Buy
+7,882
New +$2.45M 0.01% 496
2017
Q1 		– Sell
-2,630
Closed -$477K – 1276
2016
Q4 		$477K Buy
2,630
+45
+2% +$7.67K ﹤0.01% 1018
2016
Q3 		$421K Sell
2,585
-1,201
-32% -$182K ﹤0.01% 1033
2016
Q2 		$540K Buy
3,786
+65
+2% +$9.27K ﹤0.01% 926
2016
Q1 		$508K Sell
3,721
-111
-3% -$14.6K ﹤0.01% 929
2015
Q4 		$531K Buy
+3,832
New +$531K ﹤0.01% 918
2014
Q2 		– Sell
-2,748
Closed -$351K – 1431
2014
Q1 		$351K Buy
2,748
+3
+0.1% +$385 ﹤0.01% 1501
2013
Q4 		$338K Buy
2,745
+35
+1% +$4.26K ﹤0.01% 1469
2013
Q3 		$318K Sell
2,710
-14,977
-85% -$1.77M ﹤0.01% 1453
2013
Q2 		$1.98M Buy
+17,687
New +$2.07M 0.01% 621

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Suntrust Banks's BIO Position: Q3 2019 in Review

Suntrust Banks increased its Bio-Rad Laboratories Class A (BIO) stake by 0.8% in Q3 2019, buying an estimated $27.1K and bringing the position to 10,439 shares worth $3.47M. The position accounts for 0.02% of the portfolio, ranked #431.

Suntrust Banks first reported a position in BIO in Q2 2013 and has held it in 14 quarters since. 355 funds tracked by Wall St. Rank hold BIO as of Q3 2019.

  • Suntrust Banks held 10,439 shares of Bio-Rad Laboratories Class A worth $3.47M as of Q3 2019.
  • Suntrust Banks bought 83 Bio-Rad Laboratories Class A shares in Q3 2019, an estimated $27.1K.
  • Bio-Rad Laboratories Class A made up 0.02% of Suntrust Banks's portfolio in Q3 2019, its #431 holding.
  • Suntrust Banks first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 14 quarters since.
  • 355 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.